Literature DB >> 30535682

The Elevated Plus Maze Test for Measuring Anxiety-Like Behavior in Rodents.

Ann-Katrin Kraeuter1,2, Paul C Guest3, Zoltán Sarnyai4,5.   

Abstract

The elevated plus maze test is used to measure anxiety-like behavior in rodents. It can be used to gain insight into conditions such as posttraumatic stress disorder (PTSD) and other conditions marked by anxious behavior. It can also be used as a component in screening of novel compounds for anxiolytic properties. This model is based on aversion to open spaces, which is seen as the animal spending more time in the enclosed arms of the maze. This chapter describes the steps necessary for setting up and conducting the test, along with interpretation of the results.

Entities:  

Keywords:  Anxiety; Anxiolytic; Behavior; Elevated plus maze; Mouse; Rodent

Mesh:

Substances:

Year:  2019        PMID: 30535682     DOI: 10.1007/978-1-4939-8994-2_4

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  25 in total

1.  Differences between adult and adolescent male mice in approach/avoidance and expression of hippocampal NPY in response to acute footshock.

Authors:  Mariana A Cortes; Katelynn M Corder; Lynn E Dobrunz
Journal:  Stress       Date:  2021-09-21       Impact factor: 3.493

2.  Light-Dark Open Field (LDOF): A novel task for sensitive assessment of anxiety.

Authors:  Khadijah Shanazz; Rachael Dixon-Melvin; Kristopher M Bunting; Rebecca Nalloor; Almira I Vazdarjanova
Journal:  J Neurosci Methods       Date:  2021-08-18       Impact factor: 2.390

3.  Astrocyte Activation, but not Microglia, Is Associated with the Experimental Mouse Model of Schizophrenia Induced by Chronic Ketamine.

Authors:  Ying Wei; Li Xiao; Weihao Fan; Jing Zou; Hong Yang; Bo Liu; Yi Ye; Di Wen; Linchuan Liao
Journal:  J Mol Neurosci       Date:  2022-07-08       Impact factor: 2.866

Review 4.  The central nucleus of the amygdala and the construction of defensive modes across the threat-imminence continuum.

Authors:  Justin M Moscarello; Mario A Penzo
Journal:  Nat Neurosci       Date:  2022-08-01       Impact factor: 28.771

5.  Partial Endothelial Nitric Oxide Synthase Deficiency Exacerbates Cognitive Deficit and Amyloid Pathology in the APPswe/PS1ΔE9 Mouse Model of Alzheimer's Disease.

Authors:  Sara Ahmed; Yu Jing; Bruce G Mockett; Hu Zhang; Wickliffe C Abraham; Ping Liu
Journal:  Int J Mol Sci       Date:  2022-06-30       Impact factor: 6.208

Review 6.  Probing the Skin-Brain Axis: New Vistas Using Mouse Models.

Authors:  Aliće Weiglein; Evelyn Gaffal; Anne Albrecht
Journal:  Int J Mol Sci       Date:  2022-07-05       Impact factor: 6.208

Review 7.  Effects of Cannabidiol on Locomotor Activity.

Authors:  Fabrizio Calapai; Luigi Cardia; Gioacchino Calapai; Debora Di Mauro; Fabio Trimarchi; Ilaria Ammendolia; Carmen Mannucci
Journal:  Life (Basel)       Date:  2022-04-27

8.  Thymosin β4 reverses phenotypic polarization of glial cells and cognitive impairment via negative regulation of NF-κB signaling axis in APP/PS1 mice.

Authors:  Meng Wang; Li-Rong Feng; Zi-Long Li; Kai-Ge Ma; Ke-Wei Chang; Xin-Lin Chen; Peng-Bo Yang; Sheng-Feng Ji; Yan-Bing Ma; Hua Han; John Bosco Ruganzua; Wei-Na Yang; Yi-Hua Qian
Journal:  J Neuroinflammation       Date:  2021-06-28       Impact factor: 8.322

9.  Lactobacillus reuteri in its biofilm state promotes neurodevelopment after experimental necrotizing enterocolitis in rats.

Authors:  Yijie Wang; Robert M Jaggers; Pamela Mar; Jeffrey D Galley; Terri Shaffer; Adrian Rajab; Shivani Deshpande; Lauren Mashburn-Warren; John R Buzzo; Steven D Goodman; Michael T Bailey; Gail E Besner
Journal:  Brain Behav Immun Health       Date:  2021-04-06

10.  Heart failure impairs mood and memory in male rats and down-regulates the expression of numerous genes important for synaptic plasticity in related brain regions.

Authors:  Marise B Parent; Hildebrando Candido Ferreira-Neto; Ana Rafaela Kruemmel; Ferdinand Althammer; Atit A Patel; Sreinick Keo; Kathryn E Whitley; Daniel N Cox; Javier E Stern
Journal:  Behav Brain Res       Date:  2021-07-16       Impact factor: 3.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.